跳至主要内容
临床试验/NCT00699309
NCT00699309已完成不适用

A Prospective, Non-controlled, Clinical Investigation of the Taperloc® Microplasty™ Hip System

Biomet Orthopedics, LLC4 个研究点 分布在 1 个国家目标入组 98 人开始时间: 2005年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
98
试验地点
4
主要终点
Harris Hip Score

研究概览

简要总结

The purpose of this prospective clinical data-collection is to document the performance and clinical outcomes of the Taperloc® Microplasty™ Hip System.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis
  • Rheumatoid arthritis.
  • Correction of functional deformity.
  • Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques.
  • Revision of previously failed femoral head resurfacing component

排除标准

  • Absolute contraindications include:
  • infection,
  • sepsis, and
  • osteomyelitis.
  • Relative contraindications include:
  • uncooperative patient or patient with neurologic disorders who are incapable of following directions,
  • osteoporosis,
  • metabolic disorders which may impair bone formation,
  • osteomalacia,
  • distant foci of infections which may spread to the implant site,
  • rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram,
  • vascular insufficiency, muscular atrophy, or neuromuscular disease.

结局指标

主要结局

Harris Hip Score

时间窗: 5 years

次要结局

  • Incidence of revision or removals(5 Years)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验